|Bid||0.0400 x 0|
|Ask||0.0500 x 0|
|Day's Range||0.0450 - 0.0450|
|52 Week Range||0.0400 - 0.5100|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Company further advises that a liquidating trust acting on behalf of the creditors of a company that declared bankruptcy in 2006 has initiated a lawsuit against a former director-officer of the Company in the Federal District Court of Colorado. The trust has named the Company and NanoSphere Health Sciences, LLC (“Nano LLC”), as well as a number of other individuals and business entities, as third party defendants in the current action based on the trust’s assertion that Nano LLC, established in 2013, was founded on funds received from the former director-officer and thus conspired in the fraud. The trust has made no attempt to quantify the claim or amount of damages it is asserting versus the Company.
NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF) (“Nanosphere” or “the Company”) wishes to provide an update regarding its operations in Canada, along with its Canadian partner, Delta 9 Cannabis Inc, (TSX:DN) (“Delta 9”). Once produced, the initial commercial batches will require final review and approval by Delta 9 and Health Canada prior to being sold under the Delta 9 – Evolve brand in the Canadian Market.
Mr. Sutton has acted as Chairman and Chief Executive Officer since 2013, after co-founding NanoSphere with Chief Science Officer Dr. Richard Kaufman, and will continue in his role as Chairman of the Board of Directors. “Dr. Percival is the right person to lead NanoSphere into the future,” said Sutton.
Vancouver, May 29, 2019 -- May 29, 2019: NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) CEO Robert Sutton today congratulated the Governor and Legislature of.
NanoSphere Health Sciences INC (NSHS.CN) (NSHSF), the biotechnology company behind the patented NanoSphere Delivery System™, is pleased to announce that it has signed a Memorandum of Understanding with Stat Shield Technology LLC. A Division of STAT SHIELD ARMOR LLC., where Stat will act as NanoSphere’s exclusive agent for hemp-derived CBD and other products. Stat’s seasoned specialist and trendsetting Divisions covering the Aerospace, Energy, Finance, Aviation, Tier 1 finance- humanitarian programs both Military and Commercial has helped develop programs instrumental in improving business relations with governmental agencies, resulting in company growth and additional employment opportunities. NanoSphere Health Sciences has developed products that successfully leverage the next-generation NanoSphere Delivery System™.
DENVER (DATE)– NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF) (‘NanoSphere or ‘the Company’) parent company of cannabis brand Evolve Formulas, in partnership with Vertical™, the largest fully integrated company in the legal medical cannabis industry, will formally unveil the Evolve Formulas line for the California market at the Hall of Flowers trade show on April 30. The Hall of Flowers event is a licensed, industry-only, highly curated B2B trade show specifically designed to facilitate the trade of premium licensed cannabis products, including flowers, concentrate, edible, topical, and accessory categories. NanoSphere and its California production and distribution partner The Vertical Companies (Vertical) are inviting all dispensaries and cannabis distributors to join us at the Vertical booth on April 30th for a demonstration of the new product, sold under the Evolve Formulas brand.
Denver, Colorado, April 24, 2019 -- Biotechnology leader NanoSphere Health Sciences, LLC (CSE: NSHS) (OTC: NSHSF) has received formal Notice of Allowance from the Canadian.
Vancouver (April 2, 2019)– NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF) is pleased to announce its Evolve cannabis products will be available for purchase in California for the first time, after receiving final approval by the State of California. The Evolve Formulas serum will begin shipping to retail outlets next week, said NanoSphere President David Sutton. “This is another major step for our Evolve Formulas line of cannabis products, as we are now moving into the largest legal cannabis market in the world,” Sutton said.
NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF) (“NanoSphere” or the Company) is pleased to announce work has begun on the production facility for NanoSphere’s products in Canada, based at the Delta 9 Cannabis Inc. (NINE.V) (VRNDF) facility in Winnipeg, Manitoba. “We’re working hard to get production underway in April, with the goal of getting final approval for the first sales of NanoSphere products before summer,” said NanoSphere CEO Robert Sutton.
NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF) (“Nanosphere” or “the Company”) is pleased to announce that it has closed its second and final tranche of its non-brokered private placement announced on Feb. 11, 2019. Pursuant to the first tranche, the company issued 6,666,394 units at a price of 30 cents per unit for gross proceeds of $1,999,918.20. Each unit comprises one common share and a full purchase warrant exercisable to purchase a further common share at a price of 50 cents for a period of 24 months, subject to accelerated expiry if the company's shares trade at or above 75 cents for 15 consecutive days.
NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF) (“NanoSphere” or “the Company”) has for the first time received an order to export its patented Evolve Formulas CBD Hemp transdermal NanoSerum™. The initial order is for 60,000 units of the Company’s Evolve Formulas CBD Hemp transdermal NanoSerum™. The order comes from Abba Import Export S.A. de C.V. (Abba), one of the premiere distributors of health and wellness products in Mexico.
NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF), the biotechnology leader behind the patented NanoSphere Delivery System™, today signed a new letter of intent with 4Evergrn LLC, which will bring Evolve Formulas products to the Oklahoma medical and recreational cannabis markets. Nanosphere Health Sciences has developed the world’s first patented and clinically-proven delivery system for cannabis.
NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF) is pleased to announce the Company has signed a Definitive Master Licensing Agreement (the Agreement) with Delta 9 Cannabis Inc. (NINE.V) (VRNDF) (Delta 9) in a deal that opens the Canadian market to NanoSphere’s patented groundbreaking delivery technology. NanoSphere’s wholly-owned, Canadian-based subsidiary, NanoSphere Cannabis International Inc. (NCI).helped facilitate the agreement and assisted Delta 9 with the first product submission to Health Canada which has now received preliminary approval.
NanoSphere Health Sciences, Inc. (NSHS.CN) (NSHSF) announced today it has developed an anti-aging product combining Hyaluronic Acid (HA) with the Company’s patented Nanosphere Delivery System™. NanoSphere is best known for developing cannabis and CBD products that are delivered via the Company’s patented delivery system. While that enterprise continues to grow, this is NanoSphere’s first product for the cosmeceutical industry.
NanoSphere Health Sciences, Inc. (NSHS.CN) (NSHSF), the biotechnology leader behind the patented NanoSphere Delivery System™, today announced the launch of its new, DoseCode-enabled Evolve Formulas products in the Colorado market, leveraging industry-first technology from Denver-based healthcare startup Gofire. The Gofire DoseCode is a branded QR code attached to exclusive plant-based medical products found in hundreds of retailers across Colorado. When patients download the Gofire app, they can use their phones to scan the DoseCode on Evolve Formulas products, allowing them to access and save detailed descriptions, anonymous patient reviews and ratings, complete batch and lab testing information, as well as dosing recommendations from a community of peers who are also seeking relief.